-
Arteta seeks goal spree for Premier League title cushion
-
UK PM in peril as potential successors jockey for position
-
US jury awards $49.5 mn damages to Boeing 737 MAX victim's family
-
South Africa court clears way for Zuma's arms graft trial
-
Nobel winner Mukwege warns of predatory US deal for DR Congo
-
UK economy resilient as Mideast war, political risks loom
-
Russia pummels Kyiv, killing three and denting peace hopes
-
Subdued Trump left waiting for 'big hug' from Xi
-
Slot has 'every reason to believe' he will remain as Liverpool boss
-
British PM battles to stay in power amid rebellion
-
Ex-Philippine drug war enforcer flees Senate refuge
-
U2 surprise fans in Mexico City to shoot music video
-
Asia stocks uneven as investors assess high-stakes Trump-Xi talks, AI rally
-
Burberry returns to full-year profit on turnaround plan
-
Spiky, polarising, rarely dull: ups and downs of rugby's Eddie Jones
-
Denmark, Australia in the spotlight in Eurovision second semi
-
Heavy Russian strikes on Kyiv kill one, wound 31
-
Xi warns Trump on Taiwan at Beijing summit
-
Iran war and oil dominate BRICS meet in India
-
Bone appetit: Paris pups lap up treats at dog-centric spots
-
Kohli senses end after roaring back to form with IPL century
-
India bars sugar exports until September
-
Madonna, Shakira, BTS to headline first World Cup final half-time show
-
Japan takes 'half step' toward fixing slow retrial system
-
Honda posts operating loss, first since 1957
-
Madonna, Shakira, BTS to headline World Cup final half-time show
-
A quarter of World Cup games risk searing heat: scientists
-
Six hantavirus cruise passengers head to Australia
-
Suspect detained in Philippine senate gunfire: police
-
Cavs top Pistons in overtime for 3-2 series lead
-
Canadian football ready for World Cup coming out party
-
US court suspends sanctions on UN expert on Palestinians
-
Asia markets mixed as Trump-Xi summit, AI trade dominate
-
'Promised to us': The Israelis dreaming of settling south Lebanon
-
'Rare, meaningful': North Korean football team ventures into South
-
In-form Messi hits brace as Miami win 5-3 at Cincinnati in MLS
-
Historic Swiss solar-powered plane crashes into sea
-
A woman UN leader is 'historical justice,' says Ecuadoran contender for top job
-
Indian pharma fuels Africa's 'zombie drug' and opioid crisis
-
After months of blackout, Iran gives internet to select few
-
Wood urges New Zealand to 'create some history' at World Cup
-
In Washington, the fight to preserve Black cemeteries
-
US children's book author sentenced to life after poisoning husband
-
Emotional Vin Diesel leads 'Fast and Furious' tribute in Cannes
-
Eagle Plains and Sun Summit Make Greenfields Discovery at the Orbit Project, Toodoggone District, BC.
-
L Catterton, LVMH’s Investment Arm, Forms Strategic Partnership with Saint Bella Group to Fast Track Global Brand Growth
-
GEE Group Announces Filing of a Universal Shelf Registration Statement on Form S-3 for Financial Flexibility
-
Ryde is Back in Compliance With all of The NYSE American LLC Continued Listing Standards
-
Zomedica Announces "Fifth Friday at Four" Webinar on May 29th: First Quarter 2026 Financial Results and a Deep Dive into the Companion Animal VetTech Market
-
Pivotree Announces First Quarter 2026 Results
Niger to vaccinate children against malaria
Niger has approved the vaccination of children under the age of five against malaria with a ground-breaking British vaccine, the health minister has told AFP.
Malaria killed 4,000 people in the impoverished Sahel nation in 2021, most of them young children.
"The government of Niger has given a green light to use... the RTS,S/AS01 vaccine for children from birth to five years old," Illiassou Mainassara said late Thursday.
"This vaccine will arrive in Niger in the coming months, and we are already preparing for it," he added.
A cabinet statement said Niger was one of the countries approved by the World Health Organization (WHO) for the anti-malaria campaign.
In October 2021, the WHO recommended "broad use" of the world's first malaria vaccine for children in sub-Saharan Africa after reviewing a pilot programme run in Ghana, Kenya and Malawi.
The RTS,S vaccine, which is made by the British pharmaceutical giant GlaxoSmithKline, was found to considerably reduce child mortality from the Plasmodium falciparum parasite, which is most prevalent in Africa.
More than a million children in Ghana, Kenya and Malawi have now received at least one dose of the vaccine, the WHO said last week.
Niger lost 4,170 lives to malaria last year and recorded four million cases.
Niger's national coordinator for the fight against malaria, Djermakoye Hadiza Jackou, said 50 percent of cases and nearly 60 percent of deaths in the country concerned children under five.
A combination of vaccination and prevention such as mosquito nets should see the number of cases fall by at least 75 percent, she said.
WHO estimates that 627,000 people died of malaria worldwide in 2020, the latest year for which figures are available -- an increase of 12 percent over 2019.
Sub-Saharan Africa is where 95 percent of all malaria cases and 96 percent of all deaths occur.
Records of the disease date back to antiquity, with symptoms including fever, headaches and muscle pain, followed by cycles of chills, fever and sweating.
H.Gonzales--AT